← Leaderboards
Harvey J Murff
Vanderbilt University
$5,522,381
Attributed
$7,252,662
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $868.2K · FY2006–23$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$7,252,662 · 5
By mechanism
R01$5,718,133 · 3
P50$883,596 · 1
K07$650,933 · 1
Top collaborators
- Hilary A. Tindle5 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Raymond Nelson Dubois$22,706,669
- John D Imig$12,270,295
- David L Gorden$1,457,565
- Mark R Frey$5,903,884
- Robert D. Beauchamp$14,411,088
Others in their field
Top investigators on “Colorectal Cancer”
- Norman Wolmark · Nsabp Foundation, Inc.$253,344,814
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$72,920,401
- William J. Blot · Vanderbilt University$60,929,890
- Loic Le Marchand · University Of Hawaii At Manoa$57,327,999
- Ulrike Peters · Fred Hutchinson Cancer Research Center$56,201,247
- Andrew T Chan · Massachusetts General Hospital$47,099,005
Research focus
Colorectal CancerAdenomaMalignant NeoplasmsUnited StatesReportingBiological MarkersSamplingTennesseeFatty AcidsPolyunsaturated Fatty AcidsSupplementationParticipantFish OilsResearch ProposalsGeneticTissuesColorectal AdenomaMortality Vital StatisticsInflammatoryResearch PersonnelOmega-3 Fatty AcidsMembranePhospholipidsFollow-Up
Grant awards (23)
Investigating N-3 Fatty Acids to prevent Neonatal Tobacco-related outcomeS (INFANTS)$629,461
R01 · FY2023 · HD · contact PI
Investigating N-3 Fatty Acids to prevent Neonatal Tobacco-related outcomeS (INFANTS)$689,429
R01 · FY2022 · HD · contact PI
Investigating N-3 Fatty Acids to prevent Neonatal Tobacco-related outcomeS (INFANTS)$698,633
R01 · FY2021 · HD · contact PI
Investigating N-3 Fatty Acids to prevent Neonatal Tobacco-related outcomeS (INFANTS)$721,667
R01 · FY2020 · HD · contact PI
Investigating N-3 Fatty Acids to prevent Neonatal Tobacco-related outcomeS (INFANTS)$721,373
R01 · FY2019 · HD · contact PI
Genetic and Epigenetic Markers for Colorectal Adenoma Recurrence$284,052
P50 · FY2015 · CA · contact PI
Fatty acid desaturase activity, fish oil and colorectal cancer chemoprevention$255,593
R01 · FY2014 · CA · contact PI
Genetic and Epigenetic Markers for Colorectal Adenoma Recurrence$182,570
P50 · FY2014 · CA · contact PI
Fatty acid desaturase activity, fish oil and colorectal cancer chemoprevention$852
R01 · FY2014 · CA · contact PI
Fatty acid desaturase activity, fish oil and colorectal cancer chemoprevention$338,492
R01 · FY2013 · CA · contact PI
Genetic and Epigenetic Markers for Colorectal Adenoma Recurrence$194,350
P50 · FY2013 · CA · contact PI
Long-Chain Fatty Acids, Oxidative Stress and Colorectal Neoplasm Risk$101,073
R01 · FY2013 · CA · contact PI
Fatty acid desaturase activity, fish oil and colorectal cancer chemoprevention$360,410
R01 · FY2012 · CA · contact PI
Long-Chain Fatty Acids, Oxidative Stress and Colorectal Neoplasm Risk$285,132
R01 · FY2012 · CA · contact PI
Genetic and Epigenetic Markers for Colorectal Adenoma Recurrence$222,624
P50 · FY2012 · CA · contact PI
Long-Chain Fatty Acids, Oxidative Stress and Colorectal Neoplasm Risk$302,493
R01 · FY2011 · CA · contact PI
Fatty acid desaturase activity, fish oil and colorectal cancer chemoprevention$300,117
R01 · FY2011 · CA · contact PI
Long-Chain Fatty Acids, Oxidative Stress and Colorectal Neoplasm Risk$313,408
R01 · FY2010 · CA · contact PI
Mechanisms and Management of Familial Colon Cancer$130,329
K07 · FY2010 · CA · contact PI
Mechanisms and Management of Familial Colon Cancer$130,329
K07 · FY2009 · CA · contact PI
Mechanisms and Management of Familial Colon Cancer$130,329
K07 · FY2008 · CA · contact PI
Mechanisms and Management of Familial Colon Cancer$130,288
K07 · FY2007 · CA · contact PI
Mechanisms and Management of Familial Colon Cancer$129,658
K07 · FY2006 · CA · contact PI